8/6/2024NMPA Solicits Feedbacks on the Regulations on the Regulation of Export...

8/5/2024BioCity Secures CNY Hundreds of Millions in Series A+ Financing for On...

8/5/2024Snapshot of BMI System Financial Performance in H1/2024

8/5/2024Sihuan Pharma to Distribute Cellontech's Osteoporosis Drug in China

8/5/2024Genmab Assumes Full Ownership of Acasunlimab after BioNTech Exits Part...

8/5/2024CR Sanjiu to Acquire 33% Stake in Tasly Pharma Group for $869M

8/5/2024China Deepens Medical Reform through "Health-first Strategy

8/5/2024Chinese Innovative Drug R&D Trends in 2024: PharmaDJ

8/5/2024Association of Lifestyle with Sleep Health In General Population in Ch...

8/2/2024Nicholas Hall Reports Robust Chinese OTC Analgesics Market Growth in M...

8/2/2024Kyowa Kirin Restructures Asia-Pacific Operations, Sells China Business...

8/2/2024CDE Publicizes the List of Reference Formulations for GQCE Studies (85...

8/2/2024CDE Solicits Public Comments on the Technical Guidelines for Clinical ...

8/2/2024CDE Solicits Comments on the Technical Guidelines for Quality Comparab...

8/2/2024China Sees 124% Surge in Direct Trans-Provincial Medical Bill Settleme...

8/2/2024Recent Official and Executive Moves

8/1/2024Biocytogen and Ideaya Enter License Deal for Potential FIC B7H3/PTK7 T...

8/1/2024Instil Bio and ImmuneOnco Announce License Deal for PD-L1xVEGF BsAb a...

8/1/2024State Council Issues the Guiding Opinions on Improving the Long-term M...

8/1/2024NMPA Accepts NDA for Innovent's T2D Drug Mazdutide

8/1/2024WuXi Biologics Granted EMA Approval for Five Chinese Facilities

7/31/2024Shanghai Unveils Plan to Boost Biopharma R&D

7/31/2024A-Share Listed Companies Report H1/2024 Performance

7/31/2024NMPA Plans Pilot Reform for Review and Approval of Clinical Trials for...

7/31/2024NHSA and NHC Jointly Issue the Notice on Accelerating the Inclusion of...

7/31/2024Beijing to Build Intl Pharma Innovation Park to Attract Global Scienti...

7/31/2024Bio-Thera's Anticancer mAb Bevacizumab Approved in the EU

7/31/2024GE HealthCare Lowers 2024 Revenue Growth Forecast Due to Challenges in...

7/31/2024Chinese Innovative Drug R&D Trends in 2024 (Nature)

7/31/2024AstraZeneca CEO Talks Dual Supply Chain Strategy (Yahoo Finance)

Page:42/762 Total number of articles:22840: [First][<<] [40] [41] [42] [43] [44] [>>] [End]